Turato, C.; Fornari, F.; Pollutri, D.; Fassan, M.; Quarta, S.; Villano, G.; Ruvoletto, M.; Bolondi, L.; Gramantieri, L.; Pontisso, P.
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma. J. Clin. Med. 2019, 8, 171.
https://doi.org/10.3390/jcm8020171
AMA Style
Turato C, Fornari F, Pollutri D, Fassan M, Quarta S, Villano G, Ruvoletto M, Bolondi L, Gramantieri L, Pontisso P.
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma. Journal of Clinical Medicine. 2019; 8(2):171.
https://doi.org/10.3390/jcm8020171
Chicago/Turabian Style
Turato, Cristian, Francesca Fornari, Daniela Pollutri, Matteo Fassan, Santina Quarta, Gianmarco Villano, Mariagrazia Ruvoletto, Luigi Bolondi, Laura Gramantieri, and Patrizia Pontisso.
2019. "MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma" Journal of Clinical Medicine 8, no. 2: 171.
https://doi.org/10.3390/jcm8020171
APA Style
Turato, C., Fornari, F., Pollutri, D., Fassan, M., Quarta, S., Villano, G., Ruvoletto, M., Bolondi, L., Gramantieri, L., & Pontisso, P.
(2019). MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma. Journal of Clinical Medicine, 8(2), 171.
https://doi.org/10.3390/jcm8020171